Evaluation of Lipid Peroxidation, Nitric Oxide Metabolites, and Plasma Total Homocysteine Concentration in Patients with Chronic Kidney Disease

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 69

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JIML-11-2_004

تاریخ نمایه سازی: 19 فروردین 1404

چکیده مقاله:

Introduction: Numerous factors contribute to the advancement of progressive kidney damage in chronic kidney disease (CKD). Among these, oxidative damage plays a significant role in the progression of CKD. The reactions involving free radicals are recognized as a crucial element that can exacerbate oxidative damage in patients with CKD. However, the precise mechanisms underlying oxidative damage remain incompletely understood. Consequently, this study aimed to explore oxidative and other associated biochemical parameters. Materials and Methods: This case-control study included ۳۸ male and ۲۳ female patients, with mean ages of ۵۸.۹ ± ۱۵.۹ and ۶۲.۱۳ ± ۱۳.۴۳ years, respectively. At the same time, ۴۰ healthy male and ۲۲ healthy female individuals with an average age of ۶۰.۳۳ ± ۱۰.۶۲ and ۵۹.۳ ± ۶.۶۴, respectively, were selected as the control group who had no history of any diseases such as hypertension, diabetes, infection and kidney disease. Research variables including malondialdehyde (MDA), nitric oxide metabolites (nitrite/nitrate), and homocysteine (Hcy) concentration were measured in both case and control groups. Statistical analysis was done according to the obtained results. Results: There was a significant increase in homocysteine concentration in CKD patients compared to the control (P = ۰.۰۰۱). Nitrite and nitrate metabolites exhibited a substantial reduction in patients when compared to the control group (P = ۰.۰۰۱). On the other hand, malondialdehyde (MDA) showed a significant increase in patients compared to controls (P = ۰.۰۱). Conclusion: The findings indicate that homocysteine levels, lipid peroxidation, and alterations in nitric oxide may significantly contribute to the progression of oxidative damage in patients with chronic kidney disease (CKD) and may also influence the disease’s pathogenesis.

نویسندگان

زینب احمری نژاد

rsity, Shiraz, Iran

محمد رضا دیهیم

Iranian Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

محبوب لسان پزشکی

Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran

محمد تقی نجفی

Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran

فهیمه خوش نقش

Department of Clinical Laboratory Medicine, Shariat Razavi Hospital, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • . Ferenbach D.A, Bonventre J.V. Acute kidney injury and chronic ...
  • . Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi ...
  • . Ling XC, ۱ and Ko-Lin Kuo KL. Oxidative stress ...
  • . Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: production, ...
  • . Repetto M, Semprine J, Boveris A. Lipid peroxidation: chemical ...
  • . Rajul DK, Lalitha۱ DL, and Kiranmayi P. A Study ...
  • . Popolo A, Autore G, Pinto A, Marzocco S. Oxidative ...
  • . Fritz KS, Petersen D.R. An overview of the chemistry ...
  • . Grotto D, Maria LS, Valentini J, Paniz C, Schmitt ...
  • . Mian A, Aranke M, Bryan N.S. Nitric Oxide and ...
  • . Jakubowski H. Homocysteine Modification in Protein Structure/Function and Human ...
  • . Jakubowski H. Homocysteine in protein structure/function and human disease: ...
  • . Deyhim M.R, Khoshnaghsh F. Plasma homocysteine level and risk ...
  • . Abuja PM, Albertini R. Methods for monitoring oxidative stress, ...
  • . Bryan NS, Grisham MB. Methods to detect nitric oxide ...
  • . Rašic S, Rebic D, Hasi S Raši I, Šarac ...
  • . Rusu CC, Racasan S, Kacso IM, Moldovan D, Potra ...
  • . Sridhar AVS, Rao PVNS, Sivakumar V, Satish P, Shalini ...
  • . Bayes B, Pastor MC, Bonal J, Junca J, Romero ...
  • . Olokor AB, Ojogwu IL, Ugbodaga PF. Hyperhomocysteinemia in Chronic ...
  • . Daenen K, Andries A, Mekahli D, Schepdae A.V, Jouret ...
  • نمایش کامل مراجع